• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES SAPIEN 3 TRANSCATHETER HEART VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES SAPIEN 3 TRANSCATHETER HEART VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED Back to Search Results
Model Number 9600TFX29A
Device Problem Material Deformation (2976)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/23/2023
Event Type  malfunction  
Manufacturer Narrative
The investigation is ongoing.H3 other text : the device is not returning.
 
Event Description
As reported by a field clinical specialist (fcs), during first phase of alignment of a 29 mm sapien 3 valve in the aortic position via transfemoral approach, the left ventricle (lv) wire position was lost and re-crossing the native valve was unsuccessful.It was decided to remove the system and re-cross with a straight wire and catheter.Upon attempting to remove the valve and delivery system, the valve began to flair the proximal end of the valve on the tip of the sheath.The procedure was stopped and a cutdown of the right femoral artery was performed to remove the valve surgically.The procedure continued using left femoral artery and valve was successfully implanted without event.
 
Manufacturer Narrative
A supplemental mdr is being submitted for correction and additional information.The following sections of this report have been updated: corrected h.6 component codes and investigation conclusions and investigation findings.Added new information to h.6 type of investigation.The device was not returned to edwards lifesciences for evaluation.Without the device returned for evaluation, visual inspection, functional testing and dimensional analysis were unable to be completed.Imagery was provided from the site and revealed the following: patient's right access vessel had present of calcification, tortuosity.A review of the risk management documentation was performed, and no evidence of product non-conformances or labeling/ifu inadequacies were identified in the evaluation.The complaint was unable to be confirmed due to unavailability of returned device.A review of the dhr and manufacturing mitigation did not provide any indication that a manufacturing non-conformance contributed to the complaint event.A review of ifu/training materials revealed no deficiencies.In this case, ''upon attempting to remove the valve and delivery system, the valve's frame began to slightly bend outwards, or flare the proximal end of the valve on the tip of the sheath''.Per training manual, ''do not force the thv into the sheath.If resistance is felt, the thv may be caught on the sheath tip.Stop, advance thv past the sheath tip and ensure thv is centered on the flex tip.Rotate the delivery system before trying again''.Per 3mensio, the patient's access vessel had presence of calcification and tortuosity.The presence of calcification and tortuosity can create challenging pathway during delivery system withdrawal, leading to resistance.In this case, it is possible the crimped valve was not aligned with the sheath and the valve strut was caught at the sheath tip during the valve retrieval through the sheath.If excessive force was used to retrieve the valve while the strut was caught at the sheath distal tip, excessive force can bend the strut on the outflow side.As such, available information suggests that patient factors (calcification, tortuosity) and/or procedural factors (excessive device manipulation, withdrawal of crimped valve) may have contributed to the complaint event.Complaint histories for all reported events are reviewed against trending control limits monthly, and any excursions above the control limits are assessed and documented as part of this monthly review.No ifu/labeling/training manual inadequacies were identified.Therefore, no corrective or preventative action nor product risk assessment is required at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SAPIEN 3 TRANSCATHETER HEART VALVE
Type of Device
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer Contact
renee van dorne
1 edwards way
irvine, CA 92614
9492506385
MDR Report Key18125764
MDR Text Key329219075
Report Number2015691-2023-17464
Device Sequence Number1
Product Code NPT
UDI-Device Identifier00690103194364
UDI-Public(01)00690103194364(17)260207
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
1
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 12/20/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number9600TFX29A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 10/23/2023
Initial Date FDA Received11/13/2023
Supplement Dates Manufacturer Received12/18/2023
Supplement Dates FDA Received12/20/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/20/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient SexMale
-
-